🇺🇸 FDA
Patent

US 8841120

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

granted A61KA61K2039/5258A61K2039/543

Quick answer

US patent 8841120 (Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity) held by Takeda Vaccines, Inc. expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K2039/5258, A61K2039/543, A61K2039/55505, A61K2039/55572